Executive control in Parkinson's disease: Effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance

Jos J.  Adam; Hanna van Houdt; B. Scholtissen; Veerle Visser-Vandewalle; Ania Winogrodzka; A. Duits

doi:10.1016/j.neulet.2011.06.016

Executive control in Parkinson's disease: Effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance

Jos J. Adam^*, Hanna van Houdt, B. Scholtissen, Veerle Visser-Vandewalle, Ania Winogrodzka, A. Duits

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	113-117
Number of pages	5
Journal	Neuroscience Letters
Volume	500
Issue number	2
Early online date	17 Jun 2011
DOIs	https://doi.org/10.1016/j.neulet.2011.06.016
Publication status	Published - 15 Aug 2011
Externally published	Yes

Keywords

Aged
Benserazide/therapeutic use
Benzothiazoles/therapeutic use
Carbidopa/therapeutic use
Cues
*Deep Brain Stimulation
Dopamine Agents/*therapeutic use
Drug Combinations
Female
Humans
Levodopa/therapeutic use
Male
Middle Aged
Parkinson Disease/physiopathology/*psychology/therapy
Pergolide/therapeutic use
*Psychomotor Performance
Reaction Time
Subthalamic Nucleus/physiopathology
Anti-cue
Response selection
Executive control

Access to Document

10.1016/j.neulet.2011.06.016

Cite this

@article{56a00bbc0fd248108e5e523162d69f4f,

title = "Executive control in Parkinson's disease: Effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance",

keywords = "Aged, Benserazide/therapeutic use, Benzothiazoles/therapeutic use, Carbidopa/therapeutic use, Cues, *Deep Brain Stimulation, Dopamine Agents/*therapeutic use, Drug Combinations, Female, Humans, Levodopa/therapeutic use, Male, Middle Aged, Parkinson Disease/physiopathology/*psychology/therapy, Pergolide/therapeutic use, *Psychomotor Performance, Reaction Time, Subthalamic Nucleus/physiopathology, Anti-cue, Response selection, Executive control",

author = "Adam, {Jos J.} and {van Houdt}, Hanna and B. Scholtissen and Veerle Visser-Vandewalle and Ania Winogrodzka and A. Duits",

note = "PMID:21704125",

year = "2011",

month = aug,

day = "15",

doi = "10.1016/j.neulet.2011.06.016",

language = "English",

volume = "500",

pages = "113--117",

journal = "Neuroscience Letters",

issn = "0304-3940",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Executive control in Parkinson's disease

T2 - Effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance

AU - Adam, Jos J.

AU - van Houdt, Hanna

AU - Scholtissen, B.

AU - Visser-Vandewalle, Veerle

AU - Winogrodzka, Ania

AU - Duits, A.

N1 - PMID:21704125

PY - 2011/8/15

Y1 - 2011/8/15

KW - Aged

KW - Benserazide/therapeutic use

KW - Benzothiazoles/therapeutic use

KW - Carbidopa/therapeutic use

KW - Cues

KW - Deep Brain Stimulation

KW - Dopamine Agents/therapeutic use

KW - Drug Combinations

KW - Female

KW - Humans

KW - Levodopa/therapeutic use

KW - Male

KW - Middle Aged

KW - Parkinson Disease/physiopathology/psychology/therapy

KW - Pergolide/therapeutic use

KW - Psychomotor Performance

KW - Reaction Time

KW - Subthalamic Nucleus/physiopathology

KW - Anti-cue

KW - Response selection

KW - Executive control

U2 - 10.1016/j.neulet.2011.06.016

DO - 10.1016/j.neulet.2011.06.016

M3 - Article

VL - 500

SP - 113

EP - 117

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -

Executive control in Parkinson's disease: Effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance

Keywords

Access to Document

Fingerprint

Cite this